Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy
Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy
复制标题
更深入地了解建模和仿真在怀孕中的应用
DOI:
10.2174/1389200221666200907143941
复制
发表时间:
2020
影响因子:
2.3
通讯作者:
Dongyang Liu
中科院分区:
文献类型:
--
作者:
Ling Song;Cheng Cui;Ying Zhou;Zhongqi Dong;Zhiheng Yu;Yifan Xu;Tianyan Zhou;Khaled Abduljalil;Hongcan Han;Li Li;Jinbo Yang;Yangyu Zhao;Haiyan Li;Dongyang Liu
Pregnant women are often excluded from routine clinical trials. Consequently, appropriate dosing.regimens for majority of drugs are unknown in this population, which may lead to unexpected safety issue or insufficient.efficacy in this un-studied population. Establishing evidence through the conduct of clinical studies in.pregnancy is still a challenge. In recent decades, physiologically-based pharmacokinetic (PBPK) modeling has.proven to be useful to support dose selection under various clinical scenarios, such as renal and/or liver impairment,.drug-drug interactions, and extrapolation from adult to children. By integrating gestational-dependent.physiological characteristics and drug-specific information, PBPK models can be used to predict PK during.pregnancy. Population pharmacokinetic (PopPK) modeling approach also could complement pregnancy clinical.studies by its ability to analyze sparse sampling data. In the past five years, PBPK and PopPK approaches for.pregnancy have made significant progress. We reviewed recent progress, challenges and potential solutions for.the application of PBPK, PopPK, and exposure-response analysis in clinical drug development for pregnancy.